WallStSmart
TKNO

Alpha Teknova Inc

NASDAQ: TKNO · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC

$3.55
+9.91% today

Updated 2026-04-30

Market cap
$175.31M
P/E ratio
P/S ratio
4.33x
EPS (TTM)
$-0.32
Dividend yield
52W range
$2 – $7
Volume
0.1M

Alpha Teknova Inc (TKNO) Stock Valuation Analysis

Fair value estimate, historical valuation range, and quality signals for TKNO.

WallStSmart Verdict
Overvalued

Current price exceeds what fundamentals support. Risk/reward skewed unfavorably.

Smart Value Score: 28 / 100
P/E (TTM)
Not meaningful for this profile
PEG
Margin of Safety
+34.26%
Fair value $3.24 vs $3.55
EV / EBITDA
0.0x

TKNO historical valuation range

Where current P/E sits in TKNO's own 5Y range.

Insufficient historical data for 5Y percentile analysis

TKNO intrinsic value (DCF)

DCF-based fair value estimate vs current market price.

Current price
$3.55
Market value
Intrinsic value
$3.24
DCF estimate
Margin of safety
+34.26%
-8.7% upside to fair value

Intrinsic value calculated using discounted cash flow (DCF) model based on projected free cash flows, discount rate, and terminal growth assumptions. A positive margin of safety indicates the current price is below estimated fair value, providing a cushion against estimation error.

TKNO valuation signals

Quick-read green flags, caution flags, and risks based on current metrics.

Strong margin of safety
Current price 34.3% below DCF intrinsic value estimate. Meaningful downside cushion.

P/E Ratio — History

No historical P/E data available

P/S Ratio — History

Current: 4.33x

Is TKNO overvalued in 2026?

Alpha Teknova Inc (TKNO) currently trades at $3.55 per share with a market capitalization of $175,305,000.00. Based on our multi-factor framework, the stock appears richly valued with a Smart Value Score of 28/100. This score blends growth quality, financial health, and price attractiveness into a single institutional-grade read.

TKNO currently has no meaningful P/E ratio, which typically signals that the company is unprofitable, near breakeven, or emerging from a loss-making period. With a P/S ratio of 4.3x, the market is valuing the company primarily on its revenue rather than its earnings.

Our discounted cash flow model estimates TKNO's intrinsic value at $3.24 per share, against the current market price of $3.55. This implies a margin of safety of +34.26%. A meaningful cushion exists against model error, making this a reasonable risk-adjusted entry.

The Piotroski F-Score of 5/9 puts financial quality in a middling range, neither a standout strength nor an obvious red flag.

Bottom line: TKNO appears richly valued on our framework, with a Smart Value Score of 28/100. At current levels the risk/reward is skewed against the buyer. A materially lower price or significant operational improvement would be needed to change the picture.

Frequently asked questions

Is TKNO overvalued in 2026?

Based on a Smart Value Score of 28/100, TKNO appears overvalued. Current price exceeds what fundamentals currently justify.

What is TKNO's fair value?

Our DCF model estimates TKNO's intrinsic value at $3.24 per share, versus the current price of $3.55. This produces a margin of safety of +34.26%.

What P/E ratio does TKNO trade at?

TKNO does not have a meaningful P/E ratio at this time, typically a sign of unprofitability or an ongoing earnings transition.

Is TKNO a buy based on valuation?

WallStSmart does not issue buy or sell recommendations. Our Smart Value Score of 28/100 reflects the combined read on growth, quality, and price. The profile skews cautious. Consider waiting for a better price or clearer operational improvement.

How does TKNO's valuation compare to its history?

Insufficient historical valuation data exists yet for a confident percentile read on TKNO.

What is TKNO's Smart Value Score?

TKNO's Smart Value Score is 28/100. The Smart Value Score is a proprietary WallStSmart metric blending growth quality, financial health, and valuation attractiveness into a single 0-100 read. Scores above 75 are rare and indicate strong multi-factor alignment.